EX-5.1 2 exhibit51-sx8.htm EX-5.1 Document
Exhibit 5.1

logo.jpg
September 16, 2021
PROCEPT BioRobotics Corporation
900 Island Drive
Redwood City, CA 94065
Re: Form S-8 Registration Statement with respect to 10,245,724 Shares of Common Stock of PROCEPT BioRobotics Corporation
650 Town Center Drive, 20th Floor
Costa Mesa, California 92626-1925
Tel: +1.714.540.1235 Fax: +1.714.755.8290
www.lw.com
FIRM / AFFILIATE OFFICES
AustinMilan
BeijingMoscow
Brussels
New York
Century CityOrange County
ChicagoParis
DubaiRiyadh
DüsseldorfSan Diego
FrankfurtSan Francisco
HamburgSeoul
Hong KongShanghai
HoustonSilicon Valley
LondonSingapore
Los AngelesTokyo
MadridWashington, D.C.
Ladies and Gentlemen:
We have acted as special counsel to PROCEPT BioRobotics Corporation, a Delaware corporation (the “Company”), in connection with the registration by the Company of 10,245,724 shares of common stock of the Company, par value $0.00001 per share (the “Shares”), issuable under the Company’s 2008 Equity Incentive Plan, as amended (the “2008 Plan”), 2021 Equity Incentive Award Plan (the “2021 Plan”) and 2021 Employee Stock Purchase Plan (the “ESPP” and together with the 2008 Plan and the 2021 Plan, the “Plans”).
The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on September 16, 2021 (the “Registration Statement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the related prospectuses, other than as expressly stated herein with respect to the issuance of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the “DGCL”), and we express no opinion with respect to any other laws.
Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer


September 16, 2021
Page 2
image_0a.jpg
agent and registrar therefor in the name or on behalf of the purchasers and have been issued by the Company against payment therefor in the circumstances contemplated by the Plans, assuming in each case that the individual issuances, grants or awards under the Plans are duly authorized by all necessary corporate action and duly issued, granted or awarded and exercised in accordance with the requirements of law and the applicable Plans (and the agreements and awards duly adopted thereunder and in accordance therewith), the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.
This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.
Very truly yours
/s/ Latham & Watkins LLP